Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 2,182 shares at $203.75 ($445K) on 2026-04-27, disclosed to the SEC on 2026-04-29.
Scheduled sale ($445k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $203.75 | 997 | $203K | 45.6% |
| 2 | $204.39 | 1,185 | $242K | 54.4% |
| Total | $204.10 avg | 2,182 | $445K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |